Oncology Flashcards
(42 cards)
1
Q
Indication for masectomy
A
2
Q
Indication for chest wall radiation after masectomy
A
3
Q
Indication for adjuvant therapy for breast cancer
A
4
Q
Should new breast cancer mets be biopsied?
A
5
Q
Small Cell Lung Cancer characteristics
A
6
Q
A
7
Q
A
8
Q
Gastric Cancer Treatment
A
9
Q
Hereditary nonpolyposis colon cancer diagnostic criteria
A
10
Q
A
11
Q
A
12
Q
Colon cancer treatment
A
13
Q
Follow-up for colon cancer
A
14
Q
treatment of anal cancer
A
15
Q
HCC treatment
A
16
Q
A
17
Q
Treatment of Neuroendocrine tumors
A
18
Q
Ovarian Cancer Testing
A
19
Q
Ovarian Cancer Treatment
A
20
Q
Treatment of endometrial cancers
A
21
Q
Treatment of Prostate Cancer
A
22
Q
Testicular Cancer Testing
A
23
Q
Testicular Cancer Treatment
A
24
Q
RCC related disease
A
25
Treatment of RCC
26
Types of Thyroid Cancer
27
Treatment of thyroid cancer
28
Indolent Lymphoma
29
Agrressive Lymphoma
30
Hodgkins Lymphoma Treatment
31
32
33
Treatment of Neutropenic Fevers
34
35
36
High-risk prostate cancer
prostate-specific antigen (PSA) level greater than 20 ng/mL (20 µg/L), a Gleason score of 8 to 10, or evidence of extraprostatic extension of the cancer.
37
advanced-stage follicular lymphoma treatment
rituximab plus chemotherapy leads to remission in more than 90% of patients, although the disease will recur in most patients.
38
aggressive B-cell lymphomas types
diffuse large B-cell and Burkitt lymphoma
39
aggressive B-cell lymphomas treatment
Standard therapy for most patients with advanced-stage diffuse large B-cell lymphoma is rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
40
Hodgkin lymphoma diagnosis
established with a lymph node biopsy specimen showing Reed-Sternberg cells
41
Hodgkin lymphoma treatment
All patients with classic Hodgkin lymphoma, regardless of stage, receive chemotherapy(doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD)).
Patients with early-stage nodular lymphocyte–predominant Hodgkin lymphoma may be treated with radiation alone, but in the more advanced stages, they should be treated with rituximab with or without chemotherapy.
Complete response indicated by PET scan after two to three cycles of chemotherapy can allow some patients with early-stage classical Hodgkin lymphoma to forgo radiation therapy.
42
Toxicities:
Fluoropyrimidines (5-fluorouracil and capecitabine)
Epidermal growth factor receptor (EGFR) inhibitors (erlotinib and gefitinib):
Monoclonal antibodies against EGFR (cetuximab and panitumumab):
Trastuzumab:
Bleomycin:
Gemcitabine:
Cisplatin:
Bevacizumab:
Toxicities:
Fluoropyrimidines (5-fluorouracil and capecitabine): palmar-plantar erythrodysesthesia (“hand-foot syndrome”), coronary vasospasm, cerebellar toxicity
Epidermal growth factor receptor (EGFR) inhibitors (erlotinib and gefitinib): pustular acneiform eruptions, pulmonary toxicity
Monoclonal antibodies against EGFR (cetuximab and panitumumab): pustular acneiform eruptions, pulmonary toxicity
Trastuzumab: pulmonary toxicity
Bleomycin: pulmonary toxicity
Gemcitabine: Hemolytic uremic syndrome
Cisplatin: acute tubular necrosis, Peripheral neuropathy
Bevacizumab: hypertension, reversible posterior encephalopathy syndrome
pembrolizumab and nivolumab (anti–programmed death receptor-1 [PD-1]): colitis, pneumonitis, hepatitis, dermatitis, hypophysitis, thyroiditis, and adrenalitis.
